Konsultointi

Liikkeenjohdon konsultointi

Konsultointi liiketoiminnasta vastaa yhtiön Managing Partner Seppo Mäkinen. Hänellä on yli 30 vuoden kokemus alan johtotehtävistä, sekä teknilliseltä, kaupalliselta että rahoitussektorilta. Hän toimii myös aktiivisena sijoittajana alueella ja yli 25 vuoden kokemus kansainvälisestä Venture Capital liiketoiminnasta yhdistettynä noin 35 hallituspaikkaan kansainvälisissä alan yrityksissä antaa hyvän pohjan tehtävän hoitamiseen.

Taikon Advisor Oy on jo lyhyen toimintansa aikana osoittanut kykenevänsä aktiivisella panoksella auttamaan yrityksiä sekä rahoitusjärjestelyissä, M&A transaktioissa, kansainvälisissä partnerointi hankkeissa että strategisessa suunnittelussa. Asiakaskohtaisia referenssejä on yksityiskohtaisemmin listattuna sivun kohdalla referenssit.

Seppo Mäkisen taustat on tarkemmin esitetty oheisessa Seppo Mäkinen BIO kuvauksessa.

Managing Partner Seppo Mäkinen, M.Sc. (Physical Chemistry)

Seppo Mäkinen has more than 25 years of senior advisory and executive experience in board level strategic leadership and venture capital management on life science / healthcare, his special expertise is on medtech / diagnostics.

• The career includes ten years as Director in Life Sciences at Sitra (Finnish Government Fund), followed by

• thirteen years as co-founder and Managing Partner in Bio Fund Management Oy from this time also five years as President of BioFund A/S, Copenhagen. With EUR 200M under management, BioFund was one of the biggest European VC funds investing into international life sciences.

• In 2008, Seppo Mäkinen exited BioFund and

• in 2010, he founded Taikon Advisor Oy, a Finnish management consultancy firm focusing on advising and investing in life science / healthcare companies and research institutes.

Past key achievements include the listing of six companies (personally involved in three) on international stock exchanges, building up one of the leading life science Venture Capitalist in Europe, as well as the completion of over ten international trade sale transactions and further over ten international company mergers within the life science / healthcare sector. Seppo Mäkinen has served on the board level, including several chairmanships, in about thirty five large international and SME life sciences companies, including Wallac/Perkin Elmer, Kone Instruments/Thermo Instruments, Pharming NV, Exiqon A/S, Egalet A/S, Merlin Diagnostica GmbH, Profos AG, SpinX Inc. and many others.

Seppo Mäkinen is also acting as private investor investing small amounts in early stage start-up´s. In addition to this he is acting as:

• Advisor to Merieux Developpement SAS (www.merieux-developpement.com), French investment fund under the umbrella of Institute Merieux, investing in healthcare companies.

• Partner in Ventac Partners (www.ventac-partners.com) consultancy network

Seppo Mäkinen is currently Board Member in five life science/ healthcare companies:

• Ginolis Oy (www.go-gin.com / www.ginolis.com), Oulu / Uppsala based start-up company with focus on Technology platforms and manufacturing of diagnostic tests. Mr. Mäkinen is one of the co-founders of the company.

• Magnasense Technologies Oy (www.magnasense.com), Tampere based start-up company with focus on magnetic immunoassay technology. Mr. Mäkinen is also shareholder in the company.

• Arcdia International Oy (www.arcdia.com), Turku based start-up company with focus on POC diagnostic solutions for infectious diseases. Mr. Mäkinen is also minor shareholder in the company.

• Medgroup Oy (www.medgroup.fi), Vantaa based healthcare service provider with over 800 employees.

• Valirx Plc (www.valirx.com), London based AIM listed company with focus on oncology drug discovery and oncology biomarkers. Mr Mäkinen is also small shareholder in the company.

Prior to moving into the life sciences venture capital arena Seppo Mäkinen obtained a number of years of industry experience mainly on liquid chromatography, including R&D and Sales/Marketing positions in Millipore/Waters. He received his M.Sc. Degree in physical chemistry from University of Jyväskylä in 1979.